Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Betaferon TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: interferon beta-1b, inert substance
Pack: Betaferon (15 x 8 million units (250 microgram) vials, 15 x 1.2 mL inert diluent syringes), 1 pack
Brand name
(ARTG)
: BETAFERON interferon beta-1b rbe 0.25mg (8 million IU) powder for injection vial with diluent syringeDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Betaferon is indicated for the treatment of: - Ambulatory patients with relapsing-remitting multiple sclerosis (MS) characterised by at least two attacks of neurologic dysfunction over a two year period followed by complete or incomplete recovery. - Betaferon is also indicated for the reduction of frequency and severity of clinical relapses, and for the slowing of progression of disease in patients with secondary progressive multiple sclerosis. - The treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (MRI) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Subcutaneous
- White to off white cake or powder.
Component :
- Diluent, not applicable
- Subcutaneous
- Diluent: clear, colourless solution. Reconstituted solution: colourless to light yellow solution.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 15 x 0.25mg powder for injection vials with 1.2mL diluent syringes pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on September, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient interferon beta-1b
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Multiple sclerosis (MS) - myDr.com.au
Multiple sclerosis (MS) is a chronic (long-term) disease that affects the central nervous system. In MS, the protective sheath (known as myelin) that surrounds the nerve fibres in the brain and spinal cord becomes damaged. ... What are the symptoms of multiple sclerosis?
Read more on MyDoctor website
Multiple Sclerosis (MS) - Brain Disorders A-Z - Brain Foundation
Multiple Sclerosis (MS) is one of the most common acquired chronic neurological diseases in young adults, affecting over 25,000 Australians.
Read more on Brain Foundation website
Top results
